PharmiWeb.com - Global Pharma News & Resources
22-Aug-2023

Hospital-Acquired Infection Diagnostics Market Set for Exponential Growth, Predicted to Surpass USD 7.0 Billion by 2030

Hospital-acquired infection, known as nosocomial infection, can occur in people who are admitted to hospitals or healthcare institutions for various reasons. Patients of all ages, from children to the elderly, who have undergone surgery, are susceptible to such illnesses. Gastrointestinal infection, surgical-site infection, respiratory infection, bloodstream infection, urinary tract infection, bone &joint infection, and cardiovascular system infection are the most prevalent infections. Nosocomial infection, also known as hospital-acquired infection, is an infection or toxin that exists in a specific location, such as a hospital, and can be contracted by a patient who visits or is admitted to the hospital for any reason other than this infection. The most prevalent wards where HAIs arise are intensive care units, or ICUs, where doctors treat critical conditions.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

MERCK KGaA, ECOLAB, JOHNSON & JOHNSON, BECTON DICKINSON AND COMPANY, HOLOGIC, INC., BAYER SCHERING PHARMA LLC, ABBOTT LABORATORIES, DANAHER CORPORATION, STERIS PLC, PFIZER INC.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4447

The major factors that drive global hospital-acquired infection diagnostics market share are the rise in geriatric population, the development of technologically improved diagnostic technologies, and the need for HAI diagnostics in middle- and low-income nations. A rise in knowledge about hospital-acquired infections, a boom in R&D spending, enhanced healthcare infrastructure, technological improvements, and greater government actions around the world, all contribute to the expansion.

The hospital-acquired infection diagnostics market size is segmented on the basis of product, test type, application, infection type, end user, and region. By product, the industry is split into instrument &reagents and consumables. The reagents segment dominated the market. Growth of the segment is attributed to low awareness and high prevalence of hospital acquired infections in low and middle income countries. By test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. The molecular diagnosis segment dominated the market. The growth of the segment can be attributed to surge in infectious diseases, cancer, and sudden outbreak of pandemic. By application type, the market is bifurcated into disease testing and drug resistance testing. The drug-resistance testing segment dominated during the hospital-acquired infection diagnostics market forecast.

Furthermore, by infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others. The respiratory infections segment dominated the market which is attributed to high prevalence of pneumonia in hospitalized patients. Depending on end users, the market is fragmented into hospitals, clinics, ambulatory surgery centres (ASC), and others. The hospital segment accounted for the largest segment in the market which was attributed to the outburst of pandemic and sudden surge of patients.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4447

๐•๐€๐‹๐”๐„ ๐๐‘๐Ž๐๐Ž๐’๐ˆ๐“๐ˆ๐Ž๐๐’ ๐‘๐„๐‹๐€๐“๐„๐ƒ ๐“๐Ž ๐“๐‡๐„ ๐‘๐„๐๐Ž๐‘๐“:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on โ€˜Strategic Developmentsโ€™ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Editor Details

  • Company:
    • The Wire Times
Last Updated: 22-Aug-2023